Wang Jihan, Wang Yangyang, Gao Wenjie, Wang Biao, Zhao Heping, Zeng Yuhong, Ji Yanhong, Hao Dingjun
Hong Hui Hospital, Xi'an Jiaotong University, Xi'an, China.
The Tenth Research Institute of Telecommunications Technology, Xi'an, China.
PeerJ. 2017 Jun 15;5:e3450. doi: 10.7717/peerj.3450. eCollection 2017.
Some evidence suggests that bone health can be regulated by gut microbiota. To better understand this, we performed 16S ribosomal RNA sequencing to analyze the intestinal microbial diversity in primary osteoporosis (OP) patients, osteopenia (ON) patients and normal controls (NC). We observed an inverse correlation between the number of bacterial taxa and the value of bone mineral density. The diversity estimators in the OP and ON groups were increased compared with those in the NC group. Beta diversity analyses based on hierarchical clustering and principal coordinate analysis (PCoA) could discriminate the NC samples from OP and ON samples. Firmicutes, Bacteroidetes, Proteobacteria and Actinobacteria constituted the four dominant phyla in all samples. Proportion of Firmicutes was significantly higher and Bacteroidetes was significantly lower in OP samples than that in NC samples ( < 0.05), Gemmatimonadetes and Chloroflexi were significantly different between OP and NC group as well as between ON and NC group ( < 0.01). A total of 21 genera with proportions above 1% were detected and Bacteroides accounted for the largest proportion in all samples. The Blautia, Parabacteroides and Ruminococcaceae genera differed significantly between the OP and NC group ( < 0.05). Linear discriminant analysis (LDA) results showed one phylum community and seven phylum communities were enriched in ON and OP, respectively. Thirty-five genus communities, five genus communities and two genus communities were enriched in OP, ON and NC, respectively. The results of this study indicate that gut microbiota may be a critical factor in osteoporosis development, which can further help us search for novel biomarkers of gut microbiota in OP and understand the interaction between gut microbiota and bone health.
一些证据表明,肠道微生物群可调节骨骼健康。为了更好地理解这一点,我们进行了16S核糖体RNA测序,以分析原发性骨质疏松症(OP)患者、骨质减少(ON)患者和正常对照(NC)的肠道微生物多样性。我们观察到细菌分类群数量与骨密度值之间呈负相关。与NC组相比,OP组和ON组的多样性估计值增加。基于层次聚类和主坐标分析(PCoA)的β多样性分析可以区分NC样本与OP和ON样本。厚壁菌门、拟杆菌门、变形菌门和放线菌门是所有样本中的四个优势菌门。OP样本中厚壁菌门的比例显著高于NC样本,拟杆菌门的比例显著低于NC样本(<0.05),OP组与NC组以及ON组与NC组之间的芽单胞菌门和绿弯菌门也有显著差异(<0.01)。共检测到21个比例超过1%的属,拟杆菌属在所有样本中占比最大。OP组和NC组之间的布劳特氏菌属、副拟杆菌属和瘤胃球菌科属存在显著差异(<0.05)。线性判别分析(LDA)结果显示,ON组和OP组分别富集了1个门群落和7个门群落。OP组、ON组和NC组分别富集了35个属群落、5个属群落和2个属群落。本研究结果表明,肠道微生物群可能是骨质疏松症发展的关键因素,这可以进一步帮助我们寻找OP中肠道微生物群的新型生物标志物,并了解肠道微生物群与骨骼健康之间的相互作用。